Cacoub P, Guillevin L
J Mal Vasc. 1986;11(3):282-7.
The mechanisms of blood pressure regulation in periarteritis nodosa and systemic sclerodermia are discussed in the light of results of personal studies. Hypertension during PAN may be divided into two groups: hypertension related to renal microangiopathy responsible for stimulation of the renin-angiotensin-aldosterone system which often runs a severe course, sometimes accompanied by renal insufficiency and requiring treatment with beta-blocking agents or angiotensin conversion enzyme inhibitors; secondly, hypertension may not be linked to the renin-angiotensin-aldosterone system and the prognosis is then better. In systemic sclerodermia, a similar pattern may be found but it would also seem that the renin-angiotensin-aldosterone system may be stimulated in the absence of any hypertension. This rise in plasma renin activity and aldosterone preceding the onset of an acute sclerodermic renal episode has a very poor prognosis. Corticosteroid therapy may favour such a process. Other regulation mechanisms are also discussed: prostaglandins, bradykinin system.
根据个人研究结果,对结节性多动脉炎和系统性硬皮病的血压调节机制进行了讨论。结节性多动脉炎期间的高血压可分为两组:与肾微血管病相关的高血压,其会刺激肾素 - 血管紧张素 - 醛固酮系统,这种情况通常病情严重,有时伴有肾功能不全,需要用β受体阻滞剂或血管紧张素转换酶抑制剂治疗;其次,高血压可能与肾素 - 血管紧张素 - 醛固酮系统无关,此时预后较好。在系统性硬皮病中,可能会发现类似的模式,但似乎在没有任何高血压的情况下,肾素 - 血管紧张素 - 醛固酮系统也可能受到刺激。在急性硬皮病肾发作之前,血浆肾素活性和醛固酮的这种升高预后非常差。皮质类固醇治疗可能会促进这一过程。还讨论了其他调节机制:前列腺素、缓激肽系统。